For every person living with mental illness, just £9 is invested in research—compared to £228 for cancer.

That’s why Rethink Mental Illness is proud to partner with Akrivia Health on GlobalMinds, one of the largest mental health studies ever undertaken.

GlobalMinds will collect data from 50,000 people across England, Wales, and internationally who live with severe mental health conditions.

This rich dataset will help researchers better understand these conditions and develop more effective, tailored treatments. The study is run in collaboration with Cardiff University and supported by the Wellcome Trust, Johnson & Johnson, and the NIHR.

What sets GlobalMinds apart is its commitment to patient and public involvement. Global Minds ensures lived experience is central to every stage—from study design to data governance. This aligns closely with Rethink’s values, placing people severely affected by mental illness at the heart of everything we do.

GlobalMinds offers a vital opportunity to accelerate progress in diagnosis, treatment, and care. To learn more or check if you're eligible to participate, visit the GlobalMinds website.